India's cancer care system is facing a growing challenge as shortages of two essential chemotherapy drugs Cisplatin and Carboplatin continue to impact treatment schedules at hospitals across the country. The shortage is forcing oncologists to make difficult decisions, including delaying treatments, adjusting dosages, and turning to more expensive alternatives that may not offer the same level of effectiveness.
India has achieved a significant milestone in maternal and child healthcare, with more than 90 per cent of births now taking place in hospitals and healthcare facilities, according to the latest findings from the National Family Health Survey (NFHS-6).
